Optimizing Post-acute Myocardial Infarction Left Ventricular Thrombus Care: When, How, and How Long
Dimitrios Kotzadamis, Efstathios Pagourelias, Theodoros Karamitsos, Vasilios Vassilikos, Georgios Giannopoulos

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAcute Myocardial Infarction Research · Cardiac Structural Anomalies and Repair · Cardiac tumors and thrombi
Left ventricular thrombus (LVT) secondary to acute myocardial infarction (AMI) is a recognized complication, traditionally treated with vitamin K antagonists. In spite of widespread direct oral anticoagulants adoption, randomized trials remain scarce. Therefore, we commend Shah et al who demonstrated that rivaroxaban is noninferior to warfarin succeeding even earlier complete LVT resolution.1 However specific aspects of this study merit closer scrutiny.
Despite appropriate emphasis on early detection, the inclusion criterion requiring LVT identification within 7 days after AMI is overly restrictive, as it excludes a substantial number of patients who may develop thrombus beyond the first week.2 Accordingly, a follow-up imaging assessment at a later interval might have identified additional LVT cases eligible for anticoagulation.
Although acknowledged as a limitation, the imaging strategy also raises some concerns. Echocardiography without contrast agent administration likely reduced LVT detection, as contrast echocardiography may double sensitivity.3 Moreover, cardiac magnetic resonance remains the diagnostic gold standard offering superior sensitivity and specificity, even for the detection of small or mural thrombi, often missed by echocardiography, presenting however significant thromboembolic risk.4 Thus, greater reliance on advanced imaging modalities should be warranted.
A final consideration is treatment duration, as all patients, irrespective of clinical background, received 4 weeks of triple antithrombotic therapy (TAT), followed by 8 weeks of dual antithrombotic therapy. Given that, 44.4% of participants had diabetes—a high thrombotic risk subgroup—contemporary guidance suggests considering TAT extension up to 3 months when thrombotic risk predominates.5 Hence, assessing whether a prolonged TAT regimen performs even better in terms of thrombus resolution among diabetic patients with AMI and LVT would be informative for practice.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Shah J.A.Hussain J.Ahmed B.Rivaroxaban vs warfarin in acute left ventricular thrombus following myocardial infarction: RIVAWAR, an open-label RCTJACC Adv 48202510197810.1016/j.jacadv.2025.101978 PMC 1230927840706143 · doi ↗ · pubmed ↗
- 2Keren A.Goldberg S.Gottlieb S.Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction J Am Coll Cardiol 154199079080010.1016/0735-1097(90)90275-t 2307788 · doi ↗ · pubmed ↗
- 3Roifman I.Connelly K.A.Wright G.A.Wijeysundera H.C.Echocardiography vs. cardiac magnetic resonance imaging for the diagnosis of left ventricular thrombus: a systematic review Can J Cardiol 316201578579110.1016/j.cjca.2015.01.01125913472 · doi ↗ · pubmed ↗
- 4Velangi P.S.Choo C.Chen K.A.Long-term embolic outcomes after detection of left ventricular thrombus by late gadolinium enhancement cardiovascular magnetic resonance imaging: a matched cohort study Circ Cardiovasc Imaging 12112019 e 00972310.1161/CIRCIMAGING.119.009723 PMC 694114331707810 · doi ↗ · pubmed ↗
- 5Marx N.Federici M.Schütt K.2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes Eur Heart J 443920234043414010.1093/eurheartj/ehad 19237622663 · doi ↗ · pubmed ↗
